GoHealthcare Practice Solutions

Thoracic Interlaminar Epidural Steroid Injection

Medical Necessity, Prior Authorization, Documentation, Coding, Reimbursement, and Denial Prevention

Request HelpView Case Studies

GoHealthcare Results

Company-reported operational performance across specialty prior authorization and healthcare practice support engagements.

25+ YearsHealthcare operations experience

500+ Physicians and GroupsServed across specialty practices

3.5M+ Prior AuthorizationsRequests processed

98% Approval RateCompany-reported authorization approval rate

Results vary by client, payer, specialty, case mix, and contracted scope.

Request HelpExplore Case Studies

Case Study Library: https://www.gohealthcarellc.com/case-studies.html

Procedure Navigation

Select a section to review clinical, policy, coding, documentation, reimbursement, or operational requirements.

Sections 1-10

1. Overview
2. Evidence at a Glance
3. Procedure Overview and Relevant Anatomy
4. Clinical Indications and Patient Selection
5. Contraindications, Safety, and Medical Necessity
6. Conservative Treatment and Care-Pathway Sequencing
7. CMS National Guidance, Medicare NCDs, LCDs, and Billing Articles
8. Commercial Payer and BCBS Policy Variation
9. Carelon, eviCore, Cohere, and Evolent Guidelines
10. Clinical Evidence and Specialty-Society Guidance

Sections 11-20

1. Policy and Guideline Comparison Matrix
2. Prior Authorization Workflow
3. Clinical Documentation Requirements
4. Documentation Pearls
5. CPT and HCPCS Coding
6. ICD-10-CM Crosswalk
7. Modifiers, NCCI, MUE, Place of Service, and Reimbursement
8. Integrated Compliance and Quality Controls
9. Denial Prevention
10. Common Denial Reasons

Sections 21-30

1. Appeals and Peer-to-Peer Preparation
2. Operational Workflow Optimization
3. Payer Perspective
4. Clinical Pearls
5. GoHealthcare Perspective
6. GoHealthcare Insights
7. Frequently Asked Questions
8. Related Procedures
9. References and Authoritative Sources
10. Request Help

1

Procedure Library

Overview

Cervical interlaminar epidural steroid injection is an image-guided procedure in which medication is introduced into the cervical or thoracolumbar epidural space through an interlaminar approach. The procedure is generally used for selected patients with thoracic radicular pain or radiculopathy when history, examination, and imaging identify a concordant pain generator and noninvasive care has not produced adequate improvement.

The interlaminar route differs operationally from the transforaminal route. Interlaminar delivery is less root-selective and is coded under a different CPT family. Authorization obtained for cervical transforaminal injection does not automatically authorize thoracic interlaminar injection, and the performed approach must match the order, authorization, operative report, and claim.

Cervical interlaminar injection also carries important safety considerations. The thoracic epidural space is narrow, the spinal cord is nearby, and incorrect level selection, inadequate imaging, anticoagulation errors, infection, or excessive sedation can create serious risk. The authorization team does not determine procedural safety, but it must verify that the clinician has documented the rationale, planned imaging guidance, medication considerations, and relevant precautions.

Back to procedure navigation

2

Procedure Library

Evidence at a Glance

Domain	Operational conclusion
Best-supported use	Selected thoracic radicular pain or radiculopathy with concordant clinical and imaging findings.
Route	Interlaminar access provides broader epidural distribution and is not interchangeable with transforaminal access.
Imaging	Fluoroscopy or CT guidance with contrast is expected by Medicare and most major UM guidelines, subject to limited documented exceptions.
Initial treatment	Payers commonly require at least four weeks of conservative care, although certain policies allow shorter pathways when objective radiculopathy is documented.
Repeat treatment	Repeat injections require measured prior benefit, functional improvement, duration, and compliance with regional frequency limits.
Safety	FDA and multisociety sources recognize rare but serious neurologic risks. Cervical anatomy warrants strict level, imaging, anticoagulation, sedation, and infection controls.
Coding	CPT 62321 describes cervical or thoracic interlaminar epidural injection with imaging guidance. Image guidance is included and is not separately reported.

Back to procedure navigation

3

Procedure Library

Procedure Overview and Relevant Anatomy

The needle is advanced through the interlaminar space into the posterior epidural space under fluoroscopic or CT guidance. Contrast is generally used to confirm epidural placement and exclude unintended intravascular or intrathecal spread before therapeutic medication is administered. The clinician determines the safest access level and injectate based on anatomy, pathology, prior surgery, and the intended distribution.

Operational distinctions

• Cervical interlaminar ESI. Uses CPT 62321 when imaging guidance is used. It may distribute medication across more than one cervical segment but is reported as a single interlaminar injection session, not by the number of affected roots.
• Cervical transforaminal ESI. Uses CPT 64479 and, when appropriate, add-on CPT 64480. It is a targeted foraminal approach with different safety and authorization considerations.
• Thoracic interlaminar ESI. Shares CPT 62321 with thoracic interlaminar injection. The clinical record and claim must still identify the actual treated region and indication.
• Continuous catheter techniques. CPT 62324 through 62327 describe catheter-based epidural infusion services and are not substitutes for a single-shot therapeutic ESI.
• Non-image-guided coding. CPT 62320 exists for cervical or thoracic interlaminar injection without imaging guidance, but Medicare and most commercial policies generally expect imaging guidance for therapeutic ESI. Verify the applicable policy before use.

Relevant anatomy

The cervical spinal cord occupies a substantial portion of the canal, and the posterior epidural space is comparatively limited. Degenerative disc disease, disc herniation, uncovertebral changes, osteophytes, facet hypertrophy, and foraminal stenosis may produce nerve-root irritation or compression. The authorization file should translate this anatomy into a coherent clinical story: symptomatic root distribution, neurologic findings, imaging level and side, and the selected interlaminar access plan.

Back to procedure navigation

4

Procedure Library

Clinical Indications and Patient Selection

Coverage is generally strongest when the record demonstrates a band-like thoracic or chest-wall/abdominal-wall radicular pattern, functional limitation, objective or focused examination findings when present, and MRI or CT evidence of a concordant thoracic lesion. The record should also exclude or address cardiopulmonary, gastrointestinal, rib, zoster, peripheral nerve, malignancy, fracture, infection, and myelopathic causes when clinically relevant.

• Cervical disc herniation with chest-wall or abdominal-wall radicular pain or radiculopathy.
• Cervical spinal or foraminal stenosis producing a concordant radicular syndrome.
• Degenerative cervical disc disease with documented nerve-root irritation or compression.
• Persistent or recurrent thoracic radicular symptoms after surgery when a current treatable generator is documented.
• Acute herpes zoster-associated radicular pain when recognized by the governing policy and clinically appropriate.
• Other payer-recognized thoracic radicular conditions supported by examination and imaging.

Weak or commonly noncovered presentations include isolated axial thoracic pain without radicular features, nonspecific chest-wall or abdominal-wall pain without anatomic concordance, headache alone, preventive injections, predetermined series, and requests based only on an imaging abnormality without a corresponding clinical syndrome.

Patient-selection checklist

• A qualifying diagnosis and symptom pattern are documented.
• The examination supports the affected root or radicular syndrome.
• MRI or CT findings are concordant and sufficiently current under the governing policy.
• Pain or neurologic symptoms create meaningful functional limitation.
• Conservative care has been attempted, is contraindicated, or a policy-recognized exception applies.
• The physician explains why the interlaminar route is appropriate.
• No urgent surgical or alternative diagnostic pathway takes priority.
• The planned outcome can be measured after the procedure.

Back to procedure navigation

5

Procedure Library

Contraindications, Safety, and Medical Necessity

Cervical interlaminar ESI should not be treated as a routine office injection. The record must address material clinical risks and explain why the anticipated benefit justifies the procedure in the current episode of care.

• Absolute or major concerns include systemic or local infection, uncontrolled coagulopathy, allergy to required agents that cannot be mitigated, lack of a qualifying indication, and inability to perform the procedure safely.
• Signs of myelopathy, cord compression, progressive motor deficit, fracture, malignancy, epidural abscess, or another urgent condition require clinician escalation and may change the treatment pathway.
• Anticoagulant and antiplatelet management must follow current procedure-specific guidance, medication pharmacology, thrombotic risk, bleeding risk, and prescriber coordination.
• Deep sedation may interfere with patient feedback and may be inconsistent with payer policy or safety standards. Document the reason for any sedation beyond local anesthesia or minimal anxiolysis.
• Imaging guidance and contrast confirmation should be documented unless a valid exception applies.
• Pregnancy, diabetes, immunosuppression, osteoporosis, prior adverse steroid response, and cumulative corticosteroid exposure require individualized clinical consideration.

Medical necessity elements

• Qualifying radicular diagnosis supported by history and examination.
• Concordant advanced imaging identifying the relevant cervical pathology.
• Function-limiting symptoms and a documented baseline outcome measure.
• Completed conservative care or documented exception.
• Interlaminar route rationale and treatment objective.
• Image-guidance plan and relevant safety considerations.
• Regional frequency and prior-procedure review.
• For repeat injection, quantified prior improvement and duration using the same measurement method when required.

Back to procedure navigation

6

Procedure Library

Conservative Treatment and Care-Pathway Sequencing

A minimum of four weeks of appropriate conservative management is common across Medicare and major commercial or delegated UM policies. The record should identify dates, components, adherence, response, and reasons a modality was stopped. A copied phrase such as "failed conservative care" is not sufficient.

• Activity modification and education.
• Appropriate pharmacologic management, when tolerated and not contraindicated.
• Physical therapy or a structured home exercise program.
• Other noninvasive treatments appropriate to the diagnosis.
• Documented intolerance, contraindication, or inability to participate when applicable.
• Continuation of rehabilitation or a functional restoration plan after injection.

Care-pathway sequencing should also address whether surgery, urgent neurologic evaluation, electrodiagnostic testing, or a different procedural approach is more appropriate. The authorization packet should show why the requested injection is the next reasonable step now.

Back to procedure navigation

7

Procedure Library

CMS National Guidance, Medicare NCDs, LCDs, and Billing Articles

CMS does not maintain a single procedure-specific National Coverage Determination that independently establishes coverage for thoracic interlaminar ESI. Coverage is generally governed through Social Security Act reasonable-and-necessary standards, Medicare regulations, local coverage determinations, and related billing and coding articles. The applicable LCD depends on the patient location, provider jurisdiction, and date of service.

Medicare source	Operational significance
LCD L36920 - Epidural Steroid Injections for Pain Management	Requires a qualifying radicular or claudication presentation, concordant imaging, functional impact, appropriate conservative care, image guidance, and compliance with regional utilization limits.
Article A56681	Provides coding, diagnosis, documentation, and utilization guidance associated with L36920.
LCD L33906 and Article A56651	Alternative active MAC policy pair used in certain jurisdictions. Verify the exact contractor and current version.
LCD L39015, L39240, L39242 and related articles	Other active MAC policy families may govern specific jurisdictions. Requirements are similar in broad structure but diagnosis lists and wording vary.
CMS WISeR Model	Where applicable, certain procedures and jurisdictions may be subject to model-specific prior authorization or prepayment review. Verify current code and geographic scope rather than assuming universal application.

Common Medicare operational requirements

• History, examination, and radiologic testing must support a covered radicular condition.
• Pain or functional impairment should be measured at baseline and reassessed with the same scale.
• Fluoroscopy or CT with contrast is generally required, with narrow exceptions.
• Interlaminar ESI is generally limited to one spinal level per session.
• Predetermined series are not considered reasonable and necessary.
• ESI sessions are commonly limited to four per spinal region in a rolling 12-month period under current LCD language.
• Repeat treatment requires documented meaningful improvement, duration, and continued medical necessity.
• Treatment extending beyond 12 months may require additional justification and communication with the primary care clinician under the governing LCD.

Back to procedure navigation

8

Procedure Library

Commercial Payer and BCBS Policy Variation

Commercial coverage is plan-specific. The controlling document may be a national medical policy, a state or employer plan policy, a BCBS plan policy, or a delegated UM guideline. Benefit exclusions, authorization vendors, code lists, and site-of-service rules may differ even when the clinical criteria appear similar.

Payer category	Common review focus	Operational instruction
UnitedHealthcare	Radicular pain supported by history and examination, imaging concordance, conservative treatment, functional impairment, image guidance, and response-based repeat criteria.	Verify the current Commercial or Individual Exchange policy and any site-of-service rule.
Aetna / CVS Health	Qualifying radiculopathy or sciatica, duration, imaging, conservative care, and frequency limits.	Confirm the applicable clinical policy bulletin and member product.
Cigna / Evernorth	May use eviCore CMM-200 for selected plans.	Verify delegation, effective date, code list, and whether the Cigna-specific version controls.
Humana	May use internal criteria or delegated review depending on product and market.	Confirm authorization channel and product-specific policy.
BCBS plans	Criteria and UM vendor vary by state and product; some plans use Carelon or eviCore.	Do not treat one BCBS policy as national. Save the exact plan policy and authorization record.

BCBS perspective

Blue plans are independent licensees. A thoracic interlaminar ESI may be reviewed under a plan-authored policy, Carelon criteria, eviCore criteria, or another contracted program. The workflow must identify the member plan, product, host/home-plan rules when applicable, delegated vendor, authorization code list, and site-of-service requirements before clinical review begins.

Back to procedure navigation

9

Procedure Library

Carelon, eviCore, Cohere, and Evolent Guidelines

Carelon

Carelon Interventional Pain Management criteria effective June 14, 2026 address therapeutic cervical, thoracic, and lumbar ESI. The guideline generally requires a qualifying radicular condition or stenosis, functional impairment, advanced imaging, and conservative treatment. It states that at least four weeks of conservative management is generally required, with a shorter pathway possible when clear evidence of radiculopathy is documented. Repeat criteria are separate and response-based.

eviCore by Evernorth

The Cigna-specific CMM-200 guideline effective February 25, 2026 requires fluoroscopic or CT guidance with contrast except in limited circumstances, allows only one interlaminar level in the same session, rejects routine series, and applies regional frequency limits. The guideline permits up to three ESI sessions per episode in six months and no more than four sessions per region in a rolling 12 months when criteria are met. Other eviCore client versions may differ.

Cohere Health

Cohere may manage interventional pain authorization for selected health plans, but there is no single universal Cohere thoracic interlaminar ESI policy that governs every client. Verify payer delegation, procedure-code scope, portal prompts, clinical documentation requirements, and whether the plan uses proprietary criteria or payer-authored policy.

Evolent / RadMD

Evolent and RadMD administer musculoskeletal and interventional pain review for selected plans. The controlling guideline and code list may require portal access and can vary by client. Confirm whether CPT 62321 requires authorization, whether imaging recency or conservative-care thresholds apply, and how repeat injections are counted.

Back to procedure navigation

10

Procedure Library

Clinical Evidence and Specialty-Society Guidance

Clinical evidence supports potential short-term improvement for selected patients with thoracic radicular pain, but the magnitude and durability of benefit vary. Evidence should be described by indication and approach and should not be overstated. Clinical evidence informs medical judgment and appeals but does not override a benefit plan or controlling payer policy.

• CMS LCD bibliographies include studies and systematic reviews addressing fluoroscopically guided thoracic interlaminar injections and thoracic radicular pain.
• A randomized comparative-effectiveness study evaluated epidural steroid injection, conservative treatment, and combination treatment for thoracic radicular pain.
• Systematic reviews have evaluated interlaminar epidural injections with local anesthetic with or without steroid for chronic thoracic and chest-wall or abdominal-wall pain, but heterogeneity and study quality should be acknowledged.
• FDA safety communications warn of rare but serious neurologic events after epidural corticosteroid injection and note that corticosteroids are not FDA-approved specifically for epidural administration.
• Multisociety and Spine Intervention Society safety resources emphasize image guidance, contrast, careful level selection, medication selection, anticoagulation management, and avoidance of unnecessary deep sedation.

Back to procedure navigation

11

Procedure Library

Policy and Guideline Comparison Matrix

Source	Initial criteria	Repeat criteria	Frequency / level controls
Medicare LCD family	Radicular condition, concordant imaging, functional impact, conservative care, image guidance.	Measured sustained improvement and ongoing necessity.	Generally one interlaminar level per session and up to four sessions per region in 12 months.
UnitedHealthcare	Radicular presentation, examination, imaging, treatment history, functional impact.	Prior meaningful benefit and continued indication.	Policy-specific session and regional limits.
Carelon 2026	Qualifying radicular or stenotic condition, imaging, functional impairment, conservative care.	Separate response-based criteria within 12 months.	Regional session limits and one procedure approach per session may apply.
eviCore CMM-200	Indication, four-week care pathway, imaging, comprehensive pain program, fluoroscopy/CT with contrast.	Individual response; no routine series.	One interlaminar level per session; up to three sessions in six months and four per region in 12 months for the cited client version.
BCBS / Cohere / Evolent	Plan-specific.	Plan-specific.	Verify delegation, code list, region, level, and rolling-period rules.

Back to procedure navigation

12

Procedure Library

Prior Authorization Workflow

1. Identify payer, product, benefit, network, delegated UM organization, authorization channel, and site-of-service rule.

2. Confirm CPT 62321 is in scope and distinguish it from 62320 and from the transforaminal code family.

3. Retrieve and save the live policy, effective date, version, access date, and code list.

4. Validate the diagnosis against the clinical record and any payer or MAC diagnosis list.

5. Confirm symptom distribution, neurologic findings, imaging level and pathology, and functional limitation.

6. Validate conservative-treatment dates, components, adherence, response, and exceptions.

7. Confirm the physician documented why the interlaminar route is appropriate.

8. Count all cervical-region ESI sessions across interlaminar and transforaminal approaches during the look-back period.

9. For repeat requests, capture percentage pain relief, functional improvement, duration, medication change, and the scale used.

10. Confirm rendering provider, facility, place of service, requested date range, and authorization validity.

11. Submit an indexed packet or concise clinical summary when permitted.

12. Track requests for information, peer-to-peer deadlines, appeal rights, and authorization expiration.

13. Reconcile authorization, schedule, operative report, and claim before release.

14. Capture post-procedure outcomes for future medical necessity and treatment planning.

Back to procedure navigation

13

Procedure Library

Clinical Documentation Requirements

Initial request

• Chief complaint, symptom onset, duration, distribution, severity, and functional impact.
• Neurologic examination including relevant motor, sensory, and reflex findings.
• Advanced imaging findings with date, level, side, and pathology.
• Primary diagnosis and relevant secondary diagnoses.
• Dated conservative treatment with response or reason unavailable.
• Interlaminar route rationale and planned access region or level.
• Baseline pain and functional measure.
• Planned imaging guidance and contrast use or documented exception.
• Relevant medication, bleeding, infection, allergy, and sedation considerations.
• Treatment objective and post-procedure rehabilitation plan.

Repeat request

• Prior procedure date, approach, region, and authorization.
• Percentage and duration of pain relief.
• Functional improvement using the same scale or measure when required.
• Medication reduction, rehabilitation progress, or avoidance of higher-intensity care when documented.
• Recurrence pattern and current examination or imaging context.
• Reason another injection is reasonable now.
• Updated regional utilization count.

Back to procedure navigation

14

Procedure Library

Documentation Pearls

• Name the thoracic radicular pattern and affected root when clinically supported; do not document only "thoracic pain."
• Quote the relevant MRI or CT finding and explain why it matches the symptoms and examination.
• Explain why interlaminar delivery is selected rather than assuming the reviewer will infer the route.
• Document function with concrete measures such as sleep, work, driving, lifting, self-care, or rehabilitation participation.
• Use the same pain or functional scale before and after the procedure.
• Count all cervical-region ESI sessions, not only prior interlaminar injections.
• Keep order, authorization, schedule, procedure note, and claim aligned on approach, region, provider, facility, and date.
• Do not use boilerplate "series of three" language.
• Preserve the policy title, version, effective date, access date, and portal determination in the case file.

Back to procedure navigation

15

Procedure Library

CPT and HCPCS Coding

Code	Description / use	Operational cautions
62321	Injection of diagnostic or therapeutic substance, not including neurolytic substances, interlaminar epidural or subarachnoid, cervical or thoracic; with imaging guidance.	Primary code for image-guided single-shot thoracic interlaminar ESI. Imaging guidance is included.
62320	Same cervical or thoracic interlaminar service without imaging guidance.	Often inconsistent with Medicare and payer requirements for therapeutic ESI. Use only when the performed service and governing policy support it.
62324-62327	Continuous or intermittent epidural infusion with indwelling catheter, with or without imaging depending on code.	Not interchangeable with a single-shot ESI.
J-codes / supply codes	Medication may be separately reportable in some settings and payer arrangements.	Verify drug, dose, NDC, wastage rules, bundling, and site-of-service responsibility.

CPT coding is maintained by the American Medical Association. Verify the current-year code descriptor, parenthetical instructions, NCCI edits, payer policy, and contract before billing.

Back to procedure navigation

16

Procedure Library

ICD-10-CM Crosswalk

Clinical condition	Common ICD-10-CM examples	Documentation requirement
Thoracic radiculopathy	M54.14	Document symptom distribution and examination findings supporting cervical nerve-root involvement.
Cervicothoracic radiculopathy	M54.13	Use only when the documented region and clinical findings support the code.
Cervical disc disorder with radiculopathy	M51.14-M50.13 or level-specific subcodes	Select the most specific documented level and condition.
Cervical spinal stenosis	M48.04	Stenosis alone may not establish coverage; document radicular symptoms or another covered clinical syndrome.
Cervical postlaminectomy syndrome	M96.1	Document the current pain generator and radicular findings rather than relying on postoperative status alone.
Cervical spondylosis with radiculopathy	M47.24	Document degenerative pathology and clinical radiculopathy.
Thoracic radiculopathy or thoracic disc disorder	M54.14 and applicable M51-series codes	Relevant when CPT 62321 is used for a thoracic interlaminar procedure; do not use for a cervical service without supporting documentation.

This crosswalk is illustrative. The governing MAC article or payer policy may use a narrower diagnosis list. Code to the documented condition and current ICD-10-CM instructions; do not select a diagnosis solely because it appears on a coverage list.

Back to procedure navigation

17

Procedure Library

Modifiers, NCCI, MUE, Place of Service, and Reimbursement

Issue	Operational guidance
Laterality modifiers	Interlaminar ESI is not inherently reported by nerve-root laterality. Do not add RT/LT unless a payer specifically requires and accepts it.
Modifier 50	Generally not appropriate for a single interlaminar midline approach. Verify payer-specific rules before use.
Modifier 59 / X modifiers	Use only when a distinct service is supported and allowed by NCCI and payer policy. Never use to bypass an edit without documentation.
Units	CPT 62321 is generally reported as one unit for the session. Multiple affected levels do not create multiple units.
Image guidance	Included in 62321 and should not be separately billed.
MUE / NCCI	Verify the current edit files and payer-specific claim logic before submission.
Place of service	Office, ASC, and hospital outpatient settings have different payment, facility, authorization, and drug-supply rules.
Professional and facility claims	Both claims must match authorization, approach, provider, facility, date, and diagnosis.

Reimbursement varies by payer, locality, contract, site of service, provider type, drug supply, and claim edits. Forecast from contracted allowed amounts and actual adjudication history rather than billed charges or a national average. A valid authorization does not guarantee payment when the claim differs from the authorized provider, facility, date, code, region, or site of service.

Back to procedure navigation

18

Procedure Library

Integrated Compliance and Quality Controls

• Policy verification completed and source saved.
• Clinical, coding, and authorization data reconciled before scheduling.
• Regional frequency counted across approaches.
• Imaging report and physician interpretation aligned.
• Conservative care supported by dates and outcomes.
• Repeat-procedure response measured and auditable.
• Authorization matched to performed service before claim release.
• Drug, dose, lot, NDC, and wastage documented when applicable.
• Post-procedure outcome captured for clinical and payer continuity.
• Denials trended by payer, criterion, provider, location, and root cause.

Back to procedure navigation

19

Procedure Library

Denial Prevention

• Build the request from the treating clinician documentation; authorization staff should not create clinical facts.
• Distinguish axial thoracic pain from covered thoracic radicular pain.
• Provide the actual imaging finding and explain concordance.
• Document conservative care with dates, not a generic statement.
• Use CPT 62321 for the image-guided interlaminar service and do not submit transforaminal codes by habit.
• Count prior cervical ESIs across all approaches.
• For repeat requests, include percentage relief, duration, function, and same-scale comparison.
• Confirm that the requested provider, facility, date, and site of service match the authorization.
• Avoid unsupported claims that the procedure will permanently correct stenosis or eliminate the need for surgery.
• Save the governing policy and portal outcome for audit defense.

Back to procedure navigation

20

Procedure Library

Common Denial Reasons

Denial reason	Likely root cause	Prevention / response
No qualifying radiculopathy	Record documents thoracic pain but not nerve-root symptoms or findings.	Clarify symptom distribution, examination, and diagnosis before submission.
Imaging not concordant or outdated	Report is missing, old under payer criteria, or does not match the clinical level.	Obtain and summarize the relevant advanced imaging.
Insufficient conservative care	Dates, modalities, adherence, or response are absent.	Provide a dated care pathway or policy-recognized exception.
Frequency exceeded	Prior thoracic interlaminar and transforaminal sessions were not aggregated.	Run a regional utilization check before requesting.
Repeat benefit not established	Only vague improvement is documented.	Quantify pain relief, function, and duration using the same measure.
Wrong code or approach	Authorization requests 62321 but order or claim uses 64479, or vice versa.	Reconcile approach and code before submission and service.
Site of service not authorized	Facility differs from the approved location or payer requires another setting.	Verify location and site-of-service policy before scheduling.

Back to procedure navigation

21

Procedure Library

Appeals and Peer-to-Peer Preparation

An effective appeal maps the record to the exact denied criterion. It should identify the controlling policy, quote or paraphrase the relevant requirement, show where the record satisfies it, and attach only the supporting documentation. Generic statements that the procedure is common or medically accepted are rarely sufficient.

Peer-to-peer preparation checklist

• Denial letter, denial code, policy title, version, and effective date.
• One-page clinical chronology.
• Symptom distribution and objective neurologic findings.
• Imaging date and exact concordant finding.
• Conservative-treatment dates and outcomes.
• Interlaminar route rationale.
• Baseline pain and function.
• Prior ESI history and regional count.
• For repeat injection, quantified benefit and duration.
• Alternative plan if the request remains denied.

Back to procedure navigation

22

Procedure Library

Operational Workflow Optimization

• Create payer-specific cervical ESI checklists but require live policy verification.
• Use structured fields for root, region, approach, CPT, imaging date, conservative-care dates, and prior-response metrics.
• Prevent scheduling until authorization data match the order and intended site.
• Automate authorization-expiration and peer-to-peer deadline alerts.
• Reconcile authorization and operative note before claim generation.
• Track first-pass approval, turnaround time, requests for information, denial rate, peer-to-peer rate, appeal success, and authorization-related claim denial.
• Review outlier providers, payers, and sites using root-cause data rather than anecdote.

Back to procedure navigation

23

Procedure Library

Payer Perspective

The reviewer is evaluating whether the request demonstrates a covered radicular syndrome, anatomic concordance, appropriate prior care, a reasonable interlaminar route, measurable functional impact, compliant utilization, and a safe image-guided plan. The strongest submission minimizes inference. It tells one consistent story across the order, note, imaging, authorization form, schedule, procedure report, and claim.

Back to procedure navigation

24

Procedure Library

Clinical Pearls

• Cervical interlaminar and transforaminal injections are not interchangeable clinically, operationally, or for coding.
• The procedure should be driven by a radicular clinical syndrome rather than an imaging finding alone.
• Image guidance and contrast confirmation are central safety and coverage expectations.
• A single interlaminar session is not multiplied by the number of symptomatic levels.
• Objective functional measurement improves clinical continuity and repeat-authorization quality.
• New myelopathic signs or progressive deficit should trigger clinician reassessment rather than routine authorization processing.

Back to procedure navigation

25

Procedure Library

GoHealthcare Perspective

Cervical interlaminar ESI is a high-value test of operational discipline because the service sits at the intersection of patient selection, high-risk anatomy, payer policy, imaging, documentation, coding, site of service, and longitudinal outcome measurement. Most avoidable denials do not arise from one missing sentence; they arise because the clinical story changes as it moves from the physician note to the authorization request, schedule, procedure report, and claim.

GoHealthcare recommends managing each request as a closed-loop episode. The same structured data should support medical necessity, authorization, scheduling, procedural documentation, claim submission, and the next treatment decision. This approach improves approval reliability while strengthening compliance and revenue integrity.

Back to procedure navigation

26

Procedure Library

GoHealthcare Insights

• The highest-yield operational control is approach-code concordance: interlaminar equals the 62320/62321 family, not 64479/64480.
• Imaging should be summarized in the note; attaching the report alone forces the reviewer to infer concordance.
• Regional frequency must aggregate thoracic interlaminar and cervical transforaminal sessions when the policy does so.
• Repeat requests should be built from outcome data captured at the first post-procedure follow-up, not reconstructed months later.
• Authorization and revenue-cycle teams should share one source of truth for provider, facility, date, code, and site of service.
• Payer-specific variation should be stored as controlled workflow logic, not staff memory.

Back to procedure navigation

27

Procedure Library

Frequently Asked Questions

What is the primary CPT code for a fluoroscopically guided thoracic interlaminar ESI?

CPT 62321 generally describes the cervical or thoracic interlaminar epidural injection with imaging guidance. Verify the current code set and payer rules.

Is fluoroscopy billed separately?

No. Imaging guidance is included in CPT 62321 and should not be separately reported.

Can multiple thoracic levels be billed with multiple units?

Generally no. Interlaminar ESI is reported as one session, and eviCore and Medicare policies commonly limit interlaminar treatment to one level per session.

Does thoracic stenosis alone establish medical necessity?

Not necessarily. Most policies require a covered clinical syndrome such as radicular pain or radiculopathy with concordant findings and functional impairment.

Is prior authorization commonly required?

Yes. Commercial and Medicare Advantage plans frequently require authorization, often through Carelon, eviCore, Cohere, Evolent, or another vendor.

Are thoracic interlaminar and transforaminal ESI interchangeable?

No. They use different approaches, codes, risk considerations, and authorization logic.

How many injections are allowed?

Limits vary. Current Medicare LCDs commonly allow up to four ESI sessions per spinal region in 12 months. eviCore and commercial policies may use similar or different limits.

Can a series of three injections be scheduled in advance?

Most current policies reject predetermined series. Each repeat should be based on documented response and continued medical necessity.

What should be documented after the procedure?

Pain relief, functional change, duration, medication change, adverse events, and the next step in the care plan.

Does authorization guarantee payment?

No. Coverage, coding, eligibility, provider, facility, site of service, medical necessity, and claim edits must all align.

Back to procedure navigation

28

Procedure Library

Related Procedures

• Cervical Transforaminal Epidural Steroid Injection
• Thoracic Interlaminar Epidural Steroid Injection
• Lumbar Interlaminar Epidural Steroid Injection
• Lumbar Transforaminal Epidural Steroid Injection
• Caudal Epidural Steroid Injection
• Cervical Medial Branch Block
• Cervical Radiofrequency Ablation

Back to procedure navigation

29

Procedure Library

References and Authoritative Sources

1. CMS Medicare Coverage Database. LCD L36920, Epidural Steroid Injections for Pain Management. https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?LCDId=36920
2. CMS Medicare Coverage Database. Billing and Coding Article A56681. https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleId=56681
3. CMS Medicare Coverage Database. LCD L33906. https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdId=33906
4. CMS Medicare Coverage Database. Billing and Coding Article A56651. https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=56651
5. UnitedHealthcare. Epidural Steroid Injections for Spinal Pain, Commercial and Individual Exchange Medical Policy, effective June 1, 2026. https://www.uhcprovider.com/content/dam/provider/docs/public/policies/comm-medical-drug/epidural-steroid-injections-spinal-pain.pdf
6. Carelon Medical Benefits Management. Interventional Pain Management Clinical Appropriateness Guidelines, effective June 14, 2026. https://guidelines.carelonmedicalbenefitsmanagement.com/interventional-pain-management-2026-06-14/
7. eviCore by Evernorth. CMM-200 Epidural Steroid Injections, Cigna version effective February 25, 2026. https://www.evicore.com/sites/default/files/clinical-guidelines/2026-02/Cigna_Epidural%20Steroid%20Inj%20%28CMM-200%29_V1.1.2025_Eff02.25.2026_pub01.30.2026_upd02.13.2026.pdf
8. U.S. Food and Drug Administration. Drug Safety Communication: rare but serious neurologic problems after epidural corticosteroid injections. https://www.fda.gov/media/88483/download
9. Cohen SP, Hanling S, Bicket MC, et al. Epidural steroid injections compared with conservative treatment for thoracic radicular pain. Anesthesiology. 2014;121(5):1045-1055.
10. Lee JW, Hwang SY, Lee GY, et al. Fluoroscopic cervical paramidline interlaminar epidural steroid injections for thoracic radiculopathy. Skeletal Radiology. 2014;43(7):933-938.
11. Mesregah MK, Feng W, Huang WH, et al. Clinical effectiveness of interlaminar epidural injections for chronic thoracic pain: systematic review and meta-analysis. Pain Physician. 2020;23(4):335-348.
12. GoHealthcare Case Study Library. https://www.gohealthcarellc.com/case-studies.html

CMS Medicare Coverage Database. Epidural Steroid Injections for Pain Management, LCD L36920. https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?LCDId=36920

CMS Medicare Coverage Database. Epidural Steroid Injections for Pain Management, LCD L39240. https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=39240

CMS Medicare Coverage Database. Billing and Coding: Epidural Steroid Injections for Pain Management, Article A56681. https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleId=56681

UnitedHealthcare. Epidural Steroid Injections for Spinal Pain. Effective June 1, 2026. https://www.uhcprovider.com/content/dam/provider/docs/public/policies/comm-medical-drug/epidural-steroid-injections-spinal-pain.pdf

Carelon Medical Benefits Management. Interventional Pain Management Guidelines. Effective June 14, 2026. https://guidelines.carelonmedicalbenefitsmanagement.com/interventional-pain-management-2026-06-14/

eviCore by Evernorth. CMM-200 Epidural Steroid Injections. Current plan-specific guideline. https://www.evicore.com/

GoHealthcare Practice Solutions Case Study Library. https://www.gohealthcarellc.com/case-studies.html

Back to procedure navigation

30

Procedure Library

Request Help

GoHealthcare Practice Solutions supports physician practices, ambulatory surgery centers, hospitals, and healthcare organizations with prior authorization, utilization management, documentation improvement, denial prevention, appeals, coding alignment, and revenue-cycle operations for musculoskeletal procedures.

Request Help: https://www.gohealthcarellc.com/contact-us.html

Review GoHealthcare Case Studies: https://www.gohealthcarellc.com/case-studies.html

Back to procedure navigation

!

Procedure Library

Disclaimer

This publication is provided for general educational and operational purposes. It is not legal advice, medical advice, coding advice, a guarantee of coverage or payment, or a substitute for the governing payer policy, member benefit document, Medicare contractor instruction, CPT and ICD-10-CM code sets, NCCI edits, professional judgment, or applicable law. Policies, codes, payment rules, and utilization-management requirements change. Users must verify the current requirements for the patient, payer, product, jurisdiction, provider, facility, date of service, and claim. GoHealthcare company-reported performance metrics are provided for organizational context and may vary by client, payer, specialty, case mix, and contracted scope.

Strengthen Thoracic Interlaminar ESI Authorization and Revenue Integrity

GoHealthcare supports medical-necessity review, prior authorization, utilization management, clinical documentation alignment, denial prevention, appeals, and reimbursement operations for musculoskeletal specialty practices and healthcare organizations.

Request HelpView Case Studies

Case Study Library: https://www.gohealthcarellc.com/case-studies.html